Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway

Cong Zhang, Junxuan Zhou, Junjie Hu, Sheng Lei, Ming Yuan, Liang Chen, Guihong Wang and Zhenpeng Qiu

RSC Adv., 2019, 9, 20624
DOI: 10.1039/C9RA00429G

Thiourea participation in [3+2] cycloaddition with donor–acceptor cyclopropanes: a domino process to 2-amino-dihydrothiophenes

Ming-Sheng Xie, Guo-Feng Zhao, Tao Qin, Yong-Bo Suo, Gui-Rong Qu and Hai-Ming Guo

Chem. Commun., 2019, 55, 1580
DOI: 10.1039/C8CC09595G

In-flow photooxygenation of aminothienopyridinones generates iminopyridinedione PTP4A3 phosphatase inhibitors

Nikhil R. Tasker, Ettore J. Rastelli, Isabella K. Blanco, James C. Burnett, Elizabeth R. Sharlow, John S. Lazo and Peter Wipf

Org. Biomol. Chem., 2019, 17, 2448
DOI: 10.1039/C9OB00025A

Mechanism of thienopyridone and iminothienopyridinedione inhibition of protein phosphatases

Zhidian Zhang, Guennadi Kozlov, Yu Seby Chen and Kalle Gehring

Med. Chem. Commun., 2019, 10, 791
DOI: 10.1039/C9MD00175A

Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor

Kelley E. McQueeney, Joseph M. Salamoun, James C. Burnett, Nektarios Barabutis, Paula Pekic, Sophie L. Lewandowski, Danielle C. Llaneza, Robert Cornelison, Yunpeng Bai, Zhong-Yin Zhang, John D. Catravas, Charles N. Landen, Peter Wipf, John S. Lazo and Elizabeth R. Sharlow

Oncotarget, 2018, 9, 8223
DOI: 10.18632/oncotarget.23787

Disruption of Ovarian Cancer STAT3 and p38 Signaling with a Small-Molecule Inhibitor of PTP4A3 Phosphatase

John S. Lazo, Kelly N. Isbell, Sai Ashish Vasa, Danielle C. Llaneza, Ettore J. Rastelli, Peter Wipf and Elizabeth R. Sharlow

The Journal of Pharmacology and Experimental Therapeutics, 2023, 384, 429
DOI: 10.1124/jpet.122.001401

Synthesis and antiproliferative activities of amidethiophene selenocyanates

Zhiping Liu, Lijie Che, Maixia Liu, Xiyan Tang, Chunfang Gan, Haifeng Chen, Jianguo Cui and Yanmin Huang

Journal of Sulfur Chemistry, 2025, 46, 1172
DOI: 10.1080/17415993.2025.2568656

Rapid Access to Kinase Inhibitor Pharmacophores by Regioselective C–H Arylation of Thieno[2,3-d]pyrimidine

Shuya Yamada, Kaylin Nicole Flesch, Kei Murakami and Kenichiro Itami

Org. Lett., 2020, 22, 1547
DOI: 10.1021/acs.orglett.0c00143

KVX-053, a protein tyrosine phosphatase 4A3 inhibitor, ameliorates SARS-CoV-2 spike protein subunit 1–induced acute lung injury in mice

Pavel A. Solopov, Ruben Manuel Luciano Colunga Biancatelli, Tierney Day, Betsy Gregory, Elizabeth R. Sharlow, John S. Lazo and John D. Catravas

The Journal of Pharmacology and Experimental Therapeutics, 2025, 392, 100022
DOI: 10.1124/jpet.124.002154

Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders

Stephanie M. Stanford and Nunzio Bottini

Nat Rev Drug Discov, 2023, 22, 273
DOI: 10.1038/s41573-022-00618-w

Tuning the Mechanical Properties of a Polymer Semiconductor by Modulating Hydrogen Bonding Interactions

Yu Zheng, Minoru Ashizawa, Song Zhang, Jiheong Kang, Shayla Nikzad, Zhiao Yu, Yuto Ochiai, Hung-Chin Wu, Helen Tran, Jaewan Mun, Yu-Qing Zheng, Jeffrey B.-H. Tok, Xiaodan Gu and Zhenan Bao

Chem. Mater., 2020, 32, 5700
DOI: 10.1021/acs.chemmater.0c01437

Targeting phosphatases of regenerating liver (PRLs) in cancer

Min Wei, Konstantin V. Korotkov and Jessica S. Blackburn

Pharmacology & Therapeutics, 2018, 190, 128
DOI: 10.1016/j.pharmthera.2018.05.014

Regulatory role of protein tyrosine phosphatases in hematopoiesis and leukemogenesis

Xiaoting Wang, Yuyao Guan, Yizhuo Qin, Zhen Guan, guangsen Xu, Yining Dong, Zhiyuan Lu, Xiuling Zhang, Lei Zheng and Qian Zhou

Experimental and Molecular Pathology, 2026, 145, 105033
DOI: 10.1016/j.yexmp.2026.105033

The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry

Arun K. Ghosh, Margherita Brindisi and Anindya Sarkar

ChemMedChem, 2018, 13, 2351
DOI: 10.1002/cmdc.201800518

The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative

Lixia Lin, Liping Lu, Caixia Yuan, Ai Wang, Miaoli Zhu, Xueqi Fu and Shu Xing

Bioorganic & Medicinal Chemistry Letters, 2021, 41, 127981
DOI: 10.1016/j.bmcl.2021.127981

Critical Roles of Dual-Specificity Phosphatases in Neuronal Proteostasis and Neurological Diseases

Noopur Bhore, Bo-Jeng Wang, Yun-Wen Chen and Yung-Feng Liao

IJMS, 2017, 18, 1963
DOI: 10.3390/ijms18091963

One‐Pot Two Step Nazarov‐Schmidt Rearrangement for the Synthesis of Fused δ‐Lactam Systems

Yadagiri Thigulla, Santosh Ranga, Subhas Ghosal, Jayanty Subbalakshmi and Anupam Bhattacharya

ChemistrySelect, 2017, 2, 9744
DOI: 10.1002/slct.201701848

Therapeutic Targeting of Oncogenic Tyrosine Phosphatases

Rochelle Frankson, Zhi-Hong Yu, Yunpeng Bai, Qinglin Li, Ruo-Yu Zhang and Zhong-Yin Zhang

Cancer Research, 2017, 77, 5701
DOI: 10.1158/0008-5472.CAN-17-1510

Physiological and oncogenic roles of thePRLphosphatases

Serge Hardy, Elie Kostantin, Teri Hatzihristidis, Yevgen Zolotarov, Noriko Uetani and Michel L. Tremblay

The FEBS Journal, 2018, 285, 3886
DOI: 10.1111/febs.14503

Druggable cancer phosphatases

Julia P. Vainonen, Majid Momeny and Jukka Westermarck

Sci. Transl. Med., 2021, 13
DOI: 10.1126/scitranslmed.abe2967

In silico identification of putative druggable pockets in PRL3, a significant oncology target

Grace M. Bennett, Julia Starczewski and Mark Vincent C. dela Cerna

Biochemistry and Biophysics Reports, 2024, 39, 101767
DOI: 10.1016/j.bbrep.2024.101767

Asymmetric synthesis of potent and orally bioavailable thiophene-based EZH2 inhibitors

Xinrong Tian, Ken Newlander, Louis LaFrance, James Mack, James Brackley, Charles McHugh, Yanan He, Neil Johnson, Maggie Truong, Melissa B. Pappalardi, Michael T. McCabe and Steven D. Knight

Bioorganic & Medicinal Chemistry Letters, 2025, 127, 130291
DOI: 10.1016/j.bmcl.2025.130291

Phosphatase Dysregulation in Cancer: Signaling Pathways and Therapeutic Opportunities

Maryam Jama, Michael Overduin and Khaled H. Barakat

MedComm – Oncology, 2025, 4
DOI: 10.1002/mog2.70028

3D-printed cartridge system for in-flow photo-oxygenation of 7-aminothienopyridinones

Ettore J. Rastelli, Doris Yue, Caroline Millard and Peter Wipf

Tetrahedron, 2021, 79, 131875
DOI: 10.1016/j.tet.2020.131875

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells

Chirayu R. Chokshi, Muhammad Vaseem Shaikh, Benjamin Brakel, Martin A. Rossotti, David Tieu, William Maich, Alisha Anand, Shawn C. Chafe, Kui Zhai, Yujin Suk, Agata M. Kieliszek, Petar Miletic, Nicholas Mikolajewicz, David Chen, Jamie D. McNicol, Katherine Chan, Amy H. Y. Tong, Laura Kuhlmann, Lina Liu, Zahra Alizada, Daniel Mobilio, Nazanin Tatari, Neil Savage, Nikoo Aghaei, Shan Grewal, Anish Puri, Minomi Subapanditha, Dillon McKenna, Vladimir Ignatchenko, Joseph M. Salamoun, Jacek M. Kwiecien, Peter Wipf, Elizabeth R. Sharlow, John P. Provias, Jian-Qiang Lu, John S. Lazo, Thomas Kislinger, Yu Lu, Kevin R. Brown, Chitra Venugopal, Kevin A. Henry, Jason Moffat and Sheila K. Singh

Nat Med, 2024, 30, 2936
DOI: 10.1038/s41591-024-03138-9

The Solid-State Structures of Cyclic NH Carboximides

R. Aitken and Dheirya Sonecha

Crystals, 2020, 10, 606
DOI: 10.3390/cryst10070606

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

Magnus Aassved Hjort, Håkon Hov, Pegah Abdollahi, Esten Nymoen Vandsemb, Unn-Merete Fagerli, Bendik Lund, Tobias Schmidt Slørdahl, Magne Børset and Torstein Baade Rø

Exp Hematol Oncol, 2018, 7
DOI: 10.1186/s40164-018-0100-2

Development of a high-throughput screening system targeting the protein-protein interactions between PRL and CNNM

Yosuke Funato, Mai Mimura, Kazuto Nunomura, Bangzhong Lin, Shintarou Fujii, Junichi Haruta and Hiroaki Miki

Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-76269-1

Tapping the therapeutic potential of protein tyrosine phosphatase 4A with small molecule inhibitors

Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Elizabeth R. Sharlow, John S. Lazo and Peter Wipf

Bioorganic & Medicinal Chemistry Letters, 2019, 29, 2008
DOI: 10.1016/j.bmcl.2019.06.048

2-(Methoxycarbonyl)thiophen-3-yl-diazonium Salts: Efficient Precursors for the Formation of C–C Bonds in Thiophene-Containing Heterocyclic Systems

Yurii V. Ostapiuk, Oksana V. Barabash, Mary Y. Ostapiuk, Mykola Kravets, Andreas Schmidt and Mykola D. Obushak

Molecules, 2025, 30, 3758
DOI: 10.3390/molecules30183758

Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy

Jie Pan, Lisha Zhou, Chenyang Zhang, Qiang Xu and Yang Sun

Sig Transduct Target Ther, 2022, 7
DOI: 10.1038/s41392-022-01038-3

Targeting PRL phosphatases in hematological malignancies

Shiyu Xiao, Hongxia Chen, Yunpeng Bai, Zhong-Yin Zhang and Yan Liu

Expert Opinion on Therapeutic Targets, 2024, 28, 259
DOI: 10.1080/14728222.2024.2344695

Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer

John S. Lazo, Elizabeth R. Sharlow, Robert Cornelison, Duncan J. Hart, Danielle C. Llaneza, Anna J. Mendelson, Ettore J. Rastelli, Nikhil R. Tasker, Charles N. Landen and Peter Wipf

Biomolecules, 2021, 11, 969
DOI: 10.3390/biom11070969

PRL-3: unveiling a new horizon in cancer therapy

Zi-tong Cao, Jia-luo Mao, Chang-ying Huang, Han-lin Wang, Ming-zhi Wang, Wen-long Wang, Yu-bo Zhou and Jia Li

Acta Pharmacol Sin, 2025, 46, 2597
DOI: 10.1038/s41401-025-01563-1

PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth

Guennadi Kozlov, Yosuke Funato, Yu Seby Chen, Zhidian Zhang, Katalin Illes, Hiroaki Miki and Kalle Gehring

Journal of Biological Chemistry, 2020, 295, 11682
DOI: 10.1074/jbc.RA120.014464

Antibacterial activity evaluation of pleuromutilin derivatives with 4(3H)-quinazolinone scaffold against methicillin-resistant Staphylococcus aureus

Yu Deng, Yang Zhang, Xiao-Hu Chen and Cheng-Hong Li

European Journal of Medicinal Chemistry, 2023, 246, 114960
DOI: 10.1016/j.ejmech.2022.114960

Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase

John S. Lazo, Isabella K. Blanco, Nikhil R. Tasker, Ettore J. Rastelli, James C. Burnett, Sharon R. Garrott, Duncan J. Hart, Rebecca L. McCloud, Ku-Lung Hsu, Peter Wipf and Elizabeth R. Sharlow

The Journal of Pharmacology and Experimental Therapeutics, 2019, 371, 652
DOI: 10.1124/jpet.119.262188

Synthesis and evaluation of bifunctional PTP4A3 phosphatase inhibitors activating the ER stress pathway

Ettore J. Rastelli, Sara Sannino, Duncan J. Hart, Elizabeth R. Sharlow, John S. Lazo, Jeffrey L. Brodsky and Peter Wipf

Bioorganic & Medicinal Chemistry Letters, 2021, 46, 128167
DOI: 10.1016/j.bmcl.2021.128167

Catalytic Deprotonative α-Formylation of Heteroarenes by an Amide Base Generated in Situ from Tetramethylammonium Fluoride and Tris(trimethylsilyl)amine

Masanori Shigeno, Yuki Fujii, Akihisa Kajima, Kanako Nozawa-Kumada and Yoshinori Kondo

Org. Process Res. Dev., 2019, 23, 443
DOI: 10.1021/acs.oprd.8b00247

New Approaches to Difficult Drug Targets: The Phosphatase Story

John S. Lazo, Kelley E. McQueeney and Elizabeth R. Sharlow

SLAS Discovery, 2017, 22, 1071
DOI: 10.1177/2472555217721142

Small molecule targeting of PTPs in cancer

John S. Lazo, Kelley E. McQueeney, James C. Burnett, Peter Wipf and Elizabeth R. Sharlow

The International Journal of Biochemistry & Cell Biology, 2018, 96, 171
DOI: 10.1016/j.biocel.2017.09.011

Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin

Mateusz P. Czub, Adam M. Boulton, Ettore J. Rastelli, Nikhil R. Tasker, Taber S. Maskrey, Isabella K. Blanco, Kelley E. McQueeney, John H. Bushweller, Wladek Minor, Peter Wipf, Elizabeth R. Sharlow and John S. Lazo

Molecular Pharmacology, 2020, 98, 648
DOI: 10.1124/molpharm.120.000131

A Straightforward One‐Step Access to Ticlopidine Derivatives Arylated at the C5‐Position of the Thienyl Ring via Pd‐Catalyzed Direct Arylations

Dhieb Atoui, Haoran Li, Ridha Ben Salem, Thierry Roisnel, Jean‐François Soulé and Henri Doucet

Asian J Org Chem, 2019, 8, 2155
DOI: 10.1002/ajoc.201900609

Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery

Reham M. Elhassan, Xuben Hou and Hao Fang

Medicinal Research Reviews, 2022, 42, 1064
DOI: 10.1002/med.21871

Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer

Sigve Andersen, Elin Richardsen, Mehrdad Rakaee, Helena Bertilsson, Roy Bremnes, Magne Børset, Lill-Tove Busund, Tobias Slørdahl and Aamir Ahmad

PLoS ONE, 2017, 12, e0189000
DOI: 10.1371/journal.pone.0189000

A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion

Kelley E. McQueeney, Joseph M. Salamoun, Jennifer G. Ahn, Paula Pekic, Isabella K. Blanco, Heather L. Struckman, Elizabeth R. Sharlow, Peter Wipf and John S. Lazo

The FASEB Journal, 2018, 32, 5661
DOI: 10.1096/fj.201701446R

PRL-3 as a metastasis-associated phosphatase in colorectal cancer: Mechanisms and therapeutic strategies

Sarah J. Greenstein, Charmaine A. Ramlogan-Steel, Ingrid A. Wise, Rebecca J. Wilson and Jason C. Steel

Clin Exp Metastasis, 2025, 43
DOI: 10.1007/s10585-025-10385-8